Efficacy of active hexose correlated compound on survival of patients with resectable/borderline resectable pancreatic cancer: a study protocol for a double-blind randomized phase II study.
Daisuke HashimotoSohei SatoiHideki IshikawaYasuhiro KoderaKeiko KameiSatoshi HiranoTsutomu FujiiKenichiro UemuraAkihiko TsuchidaSuguru YamadaTomohisa YamamotoKiichi HirotaMitsugu SekimotoPublished in: Trials (2022)
The trial protocol has been registered in the protocol registration system at the Japan Registry of Clinical Trials (Trial ID: jRCTs051200029 ). At the time of the submission of this paper (October 2020), the protocol version is 2.0. The completion date is estimated to be November 2024.